Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly hired ...
Baymount Incorporated (TSXV: BYM.H) (the "Corporation" or "Baymount") announces today that further to its press release of September 6, 2024, the Company has terminated its previously announced ...